Codexis

Codexis Debt/Market Cap

The Debt to Market Capitalization Ratio of Codexis (CDXS) as of Oct 9, 2026 is 67.54 %. In the previous year, Debt to Market Capitalization Ratio was 55.26 % — a change of 22.23% (higher).

Debt/Market Cap

67.54 %

YoY

22.23%

Last updated:

Debt to Market Capitalization Ratio of Codexis is 2025 67.54 % . Debt to Market Capitalization Ratio of Codexis was 2024 55.26 % . It decreases by 22.23% higher compared to the previous year.

The Codexis Debt/Market Cap history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/Market Cap
Date
Debt/Market Cap
Jan 1, 2018
0.45 USD
Jan 1, 2019
24.10 USD
Jan 1, 2020
23.02 USD
Jan 1, 2021
43.97 USD
Jan 1, 2022
40.26 USD
Jan 1, 2023
14.78 USD
Jan 1, 2024
55.26 USD
Jan 1, 2025
67.54 USD
The Codexis Debt/Market Cap history
YEARDebt/Market CapYoY
67.54 %+22.23%
55.26 %+273.78%
14.78 %-63.28%
40.26 %-8.43%
43.97 %+90.99%
23.02 %-4.47%
24.10 %+5,274.07%
0.45 %-33.15%
0.67 %+71.06%
0.39 %0.00%
0.39 %—
0.00—
Access this data via the Eulerpool API

Codexis Stock analysis

What does Codexis do? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Codexis stock

Debt to Market Capitalization Ratio of Codexis is 67.54 % in 2025.

Debt to Market Capitalization Ratio of Codexis changed from 55.26 % to 67.54 %, representing a 22.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt to Market Capitalization Ratio Codexis since 2006 – with annual values, charts, and detailed analysis.

Debt/Market Cap compares total debt to the market value of equity. It provides a market-based view of financial leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt to Market Capitalization Ratio's Codexis with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Codexis

All Key Metrics — Codexis